Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 4
1973 3
1974 3
1975 2
1976 3
1977 5
1978 1
1980 1
1981 1
1982 1
1983 4
1984 4
1985 4
1986 3
1987 2
1988 1
1989 4
1990 3
1991 6
1992 4
1993 5
1994 2
1995 3
1996 6
1997 7
1998 4
1999 6
2000 10
2001 13
2002 19
2003 22
2004 35
2005 43
2006 56
2007 73
2008 78
2009 94
2010 106
2011 143
2012 152
2013 167
2014 188
2015 176
2016 184
2017 187
2018 212
2019 193
2020 242
2021 243
2022 254
2023 215
2024 179
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,991 results

Results by year

Filters applied: . Clear all
Page 1
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.
Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J, Wang K, Wang Z, Nam Y, Jiang B, Sa JK, Cho HJ, Her NG, Zhang C, Zhao Z, Zhang Y, Zeng F, Wu F, Kang X, Liu Y, Qian Z, Wang Z, Huang R, Wang Q, Zhang W, Qiu X, Li W, Nam DH, Fan X, Wang J, Jiang T. Hu H, et al. Among authors: cho hj. Cell. 2018 Nov 29;175(6):1665-1678.e18. doi: 10.1016/j.cell.2018.09.038. Epub 2018 Oct 18. Cell. 2018. PMID: 30343896 Free article.
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
Hong JY, Cho HJ, Sa JK, Liu X, Ha SY, Lee T, Kim H, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC, Kang TW, Rhim H, Lee SJ, Cristescu R, Lee J, Paik YH, Lim HY. Hong JY, et al. Among authors: cho hj. Genome Med. 2022 Jan 6;14(1):1. doi: 10.1186/s13073-021-00995-8. Genome Med. 2022. PMID: 34986867 Free PMC article. Clinical Trial.
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.
Coffey DG, Maura F, Gonzalez-Kozlova E, Diaz-Mejia JJ, Luo P, Zhang Y, Xu Y, Warren EH, Dawson T, Lee B, Xie H, Smith E, Ciardiello A, Cho HJ, Rahman A, Kim-Schulze S, Diamond B, Lesokhin A, Kazandjian D, Pugh TJ, Green DJ, Gnjatic S, Landgren O. Coffey DG, et al. Among authors: cho hj. Nat Commun. 2023 Sep 2;14(1):5335. doi: 10.1038/s41467-023-40966-8. Nat Commun. 2023. PMID: 37660077 Free PMC article.
Giant cell arteritis.
Cho HJ, Bloomberg J, Nichols J. Cho HJ, et al. Dis Mon. 2017 Mar;63(3):88-91. doi: 10.1016/j.disamonth.2016.10.006. Epub 2016 Dec 29. Dis Mon. 2017. PMID: 28041616 Review. No abstract available.
2,991 results